Autologous bone marrow‐derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single‐center, open‐label TRITON study-Reference-Cited by-同舟云学术

Autologous bone marrow‐derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single‐center, open‐label TRITON study

Published:2021-03-18 Issue:9 Volume:21 Page:3055-3065
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Reinders Marlies E. J.¹^ORCID,Groeneweg Koen E.¹^ORCID,Hendriks Sanne H.²^ORCID,Bank Jonna R.¹^ORCID,Dreyer Geertje J.¹^ORCID,Vries Aiko P. J.¹^ORCID,Pel Melissa²³^ORCID,Roelofs Helene²^ORCID,Huurman Volkert A. L.⁴^ORCID,Meij Paula⁵,Moes Dirk J. A. R.⁵^ORCID,Fibbe Willem E.²^ORCID,Claas Frans H. J.²^ORCID,Roelen Dave L.²^ORCID,Kooten Cees¹^ORCID,Kers Jesper⁶⁷⁸^ORCID,Heidt Sebastiaan²^ORCID,Rabelink Ton J.¹^ORCID,Fijter Johan W.¹^ORCID

Affiliation:

1. Department of Internal Medicine (Nephrology) and Transplant Center Leiden University Medical Center Leiden the Netherlands

2. Department of Immunology Leiden University Medical Center Leiden the Netherlands

3. NECSTGEN Leiden the Netherlands

4. Department of Transplant Surgery and Transplant Center Leiden University Medical Center Leiden the Netherlands

5. Department of Clinical Pharmacy and Toxicology Leiden University Medical Center Leiden the Netherlands

6. Department of Pathology Leiden University Medical Center Leiden the Netherlands

7. Department of Pathology Amsterdam UMCUniversity of Amsterdam Amsterdam the Netherlands

8. Van ‘t Hoff Institute for Molecular Sciences (HIMS)University of Amsterdam Amsterdam the Netherlands

Funder

Astellas Pharma Global Development

Novartis Pharma

ZonMw

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.16528

Reference31 articles.

1. Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal

2. Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015

3. Strategies for long-term preservation of kidney graft function

4. mTOR inhibitor/proliferation signal inhibitors: entering or leaving the field?;Rostaing L;J Nephrol,2010

5. Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment by Protocol Histology

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validating human induced pluripotent stem cell-specific quality control tests for the release of an intermediate drug product in a Good Manufacturing Practice quality system;Cytotherapy;2024-09

2. IDO+ Endothelial Cells in Glomeruli of Kidney Transplantation Patients With Glomerulitis;Transplantation Direct;2024-07-05

3. Good Manufacturing Practice–compliant human induced pluripotent stem cells: from bench to putative clinical products;Cytotherapy;2024-06

4. Immune modulation in transplant medicine: a comprehensive review of cell therapy applications and future directions;Frontiers in Immunology;2024-04-08

5. Menstrual blood-derived endometrial stem cell, a unique and promising alternative in the stem cell-based therapy for chemotherapy-induced premature ovarian insufficiency;Stem Cell Research & Therapy;2023-11-13